| Authors: |
Tefferi A; Division of Hematology, Mayo Clinic, Rochester, MN., Fathima S; Division of Hematology, Mayo Clinic, Rochester, MN., Abdelmagid M; Division of Hematology, Mayo Clinic, Rochester, MN., Alsugair AKA; Division of Hematology, Mayo Clinic, Rochester, MN., Aperna F; Division of Hematology, Mayo Clinic, Rochester, MN., Rezasoltani M; Division of Hematology, Mayo Clinic, Rochester, MN., Yousuf M; Division of Hematology, Mayo Clinic, Rochester, MN., Natu A; Division of Hematology, Mayo Clinic, Rochester, MN., Csizmar CM; Division of Hematology, Mayo Clinic, Rochester, MN., Gurney M; Division of Hematology, Mayo Clinic, Rochester, MN., Lasho TL; Division of Hematology, Mayo Clinic, Rochester, MN., Finke CM; Division of Hematology, Mayo Clinic, Rochester, MN., Kangal-Shamanna R; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Hammond D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Bazinet A; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., DiNardo CD; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Kadia TM; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Mangaonkar AA; Division of Hematology, Mayo Clinic, Rochester, MN., Daver N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Pardanani A; Division of Hematology, Mayo Clinic, Rochester, MN., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Zepeda-Mendoza C; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Reichard KK; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., He R; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN., Loghavi S; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Passamonti F; Dipartimento di Oncologia ed Onco-Ematologia, Università degli Studi di Milano, Milan, Italy., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Sasaki K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Larson DR; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN., Garcia-Manero G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Onida F; Hematology and Bone Marrow Transplant Center, Azienda Socio Sanitaria Territoriale Fatebenefratelli-Sacco, Università degli Studi di Milano, Milan, Italy., Gangat N; Division of Hematology, Mayo Clinic, Rochester, MN., Montalban-Bravo G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX., Patnaik MM; Division of Hematology, Mayo Clinic, Rochester, MN. |
